Researchers at the Max Planck Institute of Colloids and Interfaces (MPICI) have designed a carbohydrate sequence capable of folding into a stable secondary structure

Researchers at the Max Planck Institute of Colloids and Interfaces (MPICI) have designed a carbohydrate sequence capable of folding into a stable secondary structure. Until now, such self-folding biopolymers had only been developed for DNA and…

2 Min
More

BlueRock’s neuronal stem cell therapy for Parkinson’s disease is first to show positive results in Phase I clinical study

Investigational Bemdaneprocel (BRT-DA01) was well tolerated with no major safety issues in all 12 patients through one year

Assessment of secondary endpoints demonstrates feasibility of transplantation and evidence of cell survival and engraftment …

6 Min
More

Otto Hahn Medal for Dr. Susanne Reischauer

At its annual meeting in Göttingen, the Max Planck Society awarded the Otto Hahn Medal 2022 to the young scientist Dr Susanne Reischauer. The prize is awarded for outstanding scientific achievements during doctoral studies.

2 Min
More

CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE $30 Million Investment

Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera, a biopharmaceutical company wholly-owned by the Public Investment Fund (PIF) based in Riyadh

JV focuses on providing state-of-the-art multiomic…

7 Min
More

Max Delbrück Center has developed new technology to study virus infections

A new tool can identify cells that are actively responding to a SARS-CoV-2 infection. As reported in "Science Advances" by the Gargiulo lab, it can be used to screen for effective COVID-19 therapies and can be tailored to study other viruses as well.

3 Min
More

OMEICOS Therapeutics Receives 2.5 million Euros in Grant Funding Supporting OMT-28’s Development in Mitochondrial Diseases Through a Phase 2a Clinical Study

OMEICOS, a biopharmaceutical company developing first-in-class small molecule therapeutics based on the profound understanding of omega-3 fatty acid metabolism and physiology, announced today that the Company has received a significant grant by the…

2 Min
More

Max Delbrück Center is studying herpes encephalitis with mini-brains

The herpes simplex virus-1 can sometimes cause a dangerous brain infection. Combining an anti-inflammatory and an antiviral could help in these cases, report scientists with the Rajewsky and Landthaler labs and the Organoid Platform at the Max…

3 Min
More

Max Delbrück Center has developed a new tool to study complex genome interactions

Genome Architecture Mapping captures complex, multi-way interactions in the genome. This is different than the workhorse technique of 3D genomics, which sees mostly two-way contacts, finds a new study by a team led by Ana Pombo from the Max Delbrück…

3 Min
More

In portrait | HYBRICK – Modern laboratory and production space for the life science industry

Berlin-Brandenburg is one of the leading international life science locations. Here and throughout Germany, the healthcare industry is growing steadily. Suitable areas for research and development as well as production will therefore be needed more…

4 Min
More

REACT DX Registry Highlights Relevance of Atrial High-Rate Episode Remote Monitoring in ICD Patients

In combination with BIOTRONIK Home Monitoring® the DX ICD system is an effective and convenient way to detect AHRE and monitor atrial fibrillation events and burden

3 Min
More
Show more items